Key result
Amiodarone investigated for acute pancreatitis risk in patients with AF.
Why the study?
The potential adverse effect of amiodarone causing acute pancreatitis has not been explored in large studies.
Does amiodarone use increase the risk of acute pancreatitis in patients with atrial fibrillation?
Observational
Does amiodarone use increase the risk of acute pancreatitis in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
No results reported precludes clinical inference on amiodarone and pancreatitis risk in AF; leaves open need for further study.
Amiodarone is an antiarrhythmic frequently used in the treatment of atrial fibrillation (AF). Isolated reports have suggested that use of amiodarone may cause acute pancreatitis.1–3 This potential adverse effect of amiodarone has not been explored in large studies. We assessed whether use of amiodarone or other antiarrhythmics indicated for AF management is associated with developing acute pancreatitis in a large US population.
No takes yet. Share an insight, caveat, or question.
Alonso et al. (2015) conducted an observational in Atrial Fibrillation. Amiodarone vs. Other antiarrhythmics was evaluated on Acute pancreatitis. The abstract outlines a study assessing the association between amiodarone use and acute pancreatitis in patients with atrial fibrillation, but provides no results.
Synapse has enriched 10 related papers. Consider them for comparative context: